Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,591 | -10,291 | -64,097 | -28,212 | -14,412 |
| Depreciation Amortization | 2,586 | 1,222 | 4,261 | 2,999 | 1,741 |
| Income taxes - deferred | N/A | N/A | -9,261 | -9,358 | -9,358 |
| Accounts receivable | -365 | -685 | -1,229 | -824 | -817 |
| Accounts payable and accrued liabilities | 239 | -21 | -1,348 | -1,592 | -766 |
| Other Working Capital | -949 | -1,092 | -2,203 | -582 | -1,468 |
| Other Operating Activity | -7,444 | -2,410 | 37,936 | 8,693 | 7,187 |
| Operating Cash Flow | $-24,524 | $-13,277 | $-35,941 | $-28,876 | $-17,893 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,679 | -1,561 | -2,247 | -1,846 | -1,452 |
| Net Acquisitions | N/A | N/A | -11,714 | -11,714 | -11,714 |
| Investing Cash Flow | $-2,679 | $-1,561 | $-13,961 | $-13,560 | $-13,166 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -801 | -385 | -1,534 | -1,252 | -834 |
| Common Stock Issued | 32,454 | 31 | 83,202 | 83,190 | 74,168 |
| Common Stock Repurchased | N/A | N/A | -239 | -239 | -37 |
| Other Financing Activity | 4,781 | -1 | -3,065 | -3,066 | -2,879 |
| Financing Cash Flow | $36,434 | $-355 | $78,364 | $78,633 | $70,418 |
| Beginning Cash Position | 37,305 | 37,305 | 8,843 | 8,843 | 8,843 |
| End Cash Position | 46,536 | 22,112 | 37,305 | 45,040 | 48,202 |
| Net Cash Flow | $9,231 | $-15,193 | $28,462 | $36,197 | $39,359 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,524 | -13,277 | -35,941 | -28,876 | -17,893 |
| Capital Expenditure | -2,679 | -1,561 | -2,247 | -1,846 | -1,452 |
| Free Cash Flow | -27,203 | -14,838 | -38,188 | -30,722 | -19,345 |